Bupropion hydrochloride in attention deficit disorder with hyperactivity

Area of Science:

• Pediatric Psychiatry
• Neurodevelopmental Disorders
• Pharmacological Treatments

Background:

• Attention Deficit Disorder with Hyperactivity (ADDH) affects children's behavior and learning.
• Current treatments for ADDH include stimulant medications, but alternative options are being explored.

Purpose of the Study:

• To evaluate the safety and efficacy of bupropion for treating ADDH in children.
• To compare bupropion's effects against a placebo in a pediatric population.

Main Methods:

• A multisite, double-blind, placebo-controlled trial involving children aged 6-12 diagnosed with ADDH.
• Participants received either bupropion (3-6 mg/kg/day) or placebo, with efficacy assessed using standardized questionnaires and cognitive tests.

Main Results:

• Bupropion demonstrated significant improvements in conduct problems and hyperactivity, as reported by teachers and parents.
• Cognitive assessments, including the Continuous Performance Test, also showed significant treatment effects.
• While generally well-tolerated, bupropion use was associated with a higher incidence of dermatological reactions compared to placebo.

Conclusions:

• Bupropion may serve as a valuable therapeutic option for children with ADDH.
• Comparative studies with established treatments like methylphenidate are recommended to ascertain bupropion's relative clinical benefits.